Protagen AG is a leading provider of products, services and software solutions for protein research. Operating internationally to provide customers with products and services of the highest quality, Protagen has offices in Dortmund, Germany and New Jersey, USA. The Company has a decade of experience in applying the most advanced protein research tools and techniques to improve the efficiency of the drug discovery and development process.
Protagen provides customers with a flexible service program, including protein analysis (also GMP-compliant) and protein identification, differential protein display, antibody validation and specification, antigen identification, and full data management services.
As an innovator in protein biochips, Protagen has developed UNIclone®, a patent protected platform for protein expression libraries and protein arrays, and UNIchip®, a versatile and highly efficient series of protein biochip products for antibody development. In addition, UNIarrayTM a highly efficient technology platform for biomarker discovery has been established in industrial scale within the company and is currently employed for biomarker finding in Multiple Sclerosis and Rheumatoid Arthritis.